Achte K.A., Hillbom E., Aalberg V. (1969) Psychoses following war brain injuries. Acta Psychiatr Scand45: 1-18
2.
Akiskal H.S. (1982) Factors associated with incomplete recovery in primary depressive illness. J Clin Psychiatr43: 226-271
3.
Akiskal H.S. (1985) A proposed clinical approach to chronic and 'resistant' depressions: evaluation and treatment. J Clin Psychiatr46: 32-36
4.
Akiskal H.S. (1990) Towards a definition of dysthymia: boundaries with personality and mood disorders. In Burton S W, Akiskal H S (eds), Dysthymic disorder. Gaskell Royal College of Psychiatrists , pp. 1-12
5.
Akiskal H.S., Bitar A.H., Puzantian V.R., Rosenthal T.L., Walker P.W. (1978) The nosological status of neurotic depression: a prospective three to four year examination in light of the primary-secondary and unipolar-bipolar dichotomies. Arch Gen Psychiatr35: 756-766
6.
Akiskal H.S., Rosenthal T.L., Haykal R.F., Lemmi H., Rosenthal R.H., Scott-Strauss A. (1980) Characterological depressions. Arch Gen Psychiatr37: 777-783
7.
Akiskal H.S., King D., Rosenthal T.L., Parks W.W. (1981) Chronic depressions: part I—clinical and familial characteristics in 137 probands. J Affect Disorders3: 297-315
8.
Akiskal H.S., Chen S.E., Davis G.C., Puzantian V.R., Kashagarian M., Bolinger J.M. (1985) Borderline: an adjective in search of a name. J Clin Psychiatr46: 41-48
American Psychiatric Association (1985) Tricyclic antidepressant-blood level measurements and clinical outcome on APA task force report. Am J Psychiatr142: 155-162
11.
American Psychiatric Association (1988) Diagnostic and statistical manual of mental disorders, DSM III-R, 1st edn. APA, Washington DC
12.
Andreasen N.C., Winokur G. (1979) Newer experimental methods for the classification of depression. Arch Gen Psychiatr36: 447-452
13.
Aronson T.A., Shukla S., Gujavarty K., Hoff A., Di Buono M., Khan E. ( 1988) Relapse in delusional depression: a retrospective study of the course of treatment. Comp Psychiatr29: 12-21
14.
Asberg M., Evans D.A., Sjoqvist F. (1971) Genetic control of nortriptyline kinetics in man: a study of relatives of propositi with high plasma concentrations. J Med Genet8: 129-135
15.
Asher R. (1949) Myxoedematous madness. Br Med J2: 555-562
16.
Ayd F.J. (1984) Long term treatment of chronic depression: 15 year experience with doxepin HCI. J Clin Psychiatr45: 39-46
17.
Barker W.A., Scott J., Eccleston D. (1987) The Newcastle chronic depression study: results of a treatment regime. Int Clin Psychopharmacol2: 261-272
18.
Bassett A.S., Remick R.A., Beiser M., Miles J.E., Wilt F. ( 1986) The art of pharmacotherapy in depressed outpatients. Can J Psychiatr31: 852-856
19.
Berrios G.E., Quemada J.I. (1990) Depressive illness in multiple sclerosis: clinical and theoretical aspects of the association. Br J Psychiatr156: 10-16
20.
Betts T.A. (1981) Depression, anxiety and epilepsy. In Reynolds E H, Trimble M R (eds), Epilepsy and psychiatry. Churchill Livingstone, London, pp. 60-71
21.
Borst G.C., Eil C., Burman K. (1983) Euthyroid hyperthyroxinaemia. Ann Intern Med98: 366-378
22.
Boyd H.I., Weissman M.M. (1981) Epidemiology of affective disorders. Arch Gen Psychiatr38: 1039-1046
23.
Bridges P.K. (1983) and a small dose of an antidepressant might help. BrJ Psychiatr142: 626-628
24.
British National Formulary (1990) Number 21. British Medical Association and Royal Pharmaceutical Society of Great Britain
25.
Buchsbaum M.S., Wu J., De Lisi L.E., Holcomb H., Kessler R., Johnson J., King A.C., Hazlett E., Langston K., Post R.M. (1986) Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F] 2-deoxyglucose in affective illness. J Affect Disorders10: 137-152
26.
Bunney W.E. (1977) The switch process in manic depressive psychosis . Ann Intern Med87: 31
27.
Callies A., Popkin M. (1987) Antidepressant treatment of medical-surgical inpatients by non-psychiatric physicians. Arch Gen Psychiatr44: 157-160
28.
Carney M W P, Roth M., Garside R.F. (1965) The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatr111: 659-674
29.
Cassano G.B., Maggini C., Akiskal H. (1983) Short-term, subchronic and chronic sequelae of affective disorders. Psychiatr Clin North Am6: 55-67
30.
Cohen S.I. (1980) Cushing's syndrome: a psychiatric study of 29 patients . Br J Psychiatr136: 120-124
Cowen P.J., Elphick M. (1990) Similar effects of lithium and carbamazepine on 5.HT mediated neuroendocrine responses and sleep. Abstracts of the annual meeting of the British Association of Psychopharmacology p. 19.
Decina P., Guthrie E.B., Sackeim H.A., Kahn D., Militz S. (1987) Continuation ECT in the management of relapses of major affective disorder. Acta Psychiatr Scand75: 559-562
36.
Delgado P.L., Price L.H., Charney D.S., Heninger G.R. (1988) Efficacy of fluvoxamine in treatment—refractory depression. J Affect Disorders15: 55-60
37.
Denko J.D., Kaelbling R. (1962) The psychiatric aspects of hypoparathyroidism. Acta Psychiatr Scand (Suppl) 164: 1-70
38.
Dewhurst D. (1969) The neurosyphilitic psychoses today: a survey of 91 cases. Br J Psychiatr115: 31-38
39.
Dinan T.G., Barry S. (1989) A comparison of electroconvulsive therapy with a combined lithium and tricyclic combination among depressed tricyclic non responders. Acta Psychiatr Scand80: 97-100
40.
Dunner D.L., Fieve R.R. (1974) Clinical factors in lithium prophylaxis failure . Arch Gen Psychiatr30: 229-233
Emrich H.M., Dose M., Vonzerssen D. (1985) The use of sodium valproate, carbamazepine and oxcarbamazepine in patients with affective disorders. J Affect Disorders8: 243-250
43.
Gewirtz G.R., Malaspina D., Hatterer J.A., Feureisen S., Klein D., Gorman J.M. (1988) Occult thyroid dysfunction in patients with refractory depression. Am J Psychiatr145: 1012-1014
44.
Gillespie R.D. (1929) The clinical differentiation of types of depression . Guy's Hospital Reports79: 306-344
45.
Gitlin M.J., Weiner H., Fairbanks L., Hershman J.M., Friedfeld N. (1987) Failure of T3 to potentiate tricyclic anti-depressant response. J Affect Disorders13 : 267-272
46.
Glue P.W., Cowen P.J., Nutt D.J., Kolakowska T., Grahame-Smith D.G. (1986) The effect of lithium on 5-HT mediated neuroendocrine responses and 5-HT receptors. Psychopharmacology90: 398-402
47.
Goktepe E.O., Young L.B., Bridges P.K. (1975) A further review of the results of stereotactic subcaudate tractotomy. Br J Psychiatr126: 270-280
48.
Goodwin F.K., Jamison K.R. (1984) The natural course of manic depressive illness . In Post R M, Ballenger J C (eds), Neurobiology of mood disorders. Williams and Wilkin, Baltimore, pp. 20-37
49.
Goodwin F.K., Murphy D.L., Dunner D.L., Bunney W.E. (1972) Lithium response in unipolar versus bipolar depression . Am J Psychiatr129: 44-47
50.
Goodwin F.K., Prange A.J., Post R.M., Muscelttola G., Lipton M.A. (1982) Potentiation of anti-depressant effects by L-triiodothyronine in tricyclic non-responses. Am J Psychiatr139: 34-38
51.
Greer S., Silberfarb P.M. (1982) Psychological concomitants of cancer: current state of research. Psychol Med12: 563-573
52.
Gurland B., Ganz V.F., Fleiss J.L., Zubin J. (1972) The study of psychiatric symptoms of systemic lupus erythematosus: a critical review. Psychosomatic Med34: 199-206
53.
Guze S.B., Robins E. (1970) Suicide and primary affective disorders. Br J Psychiatr117: 437-438
54.
Guze S.B., Woodruff R.A., Clayton P.J. (1971) Secondary affective disorder: a study of 95 cases . Psychol Med1: 426-428
55.
Hale A.S., Procter A.W., Bridges P.K. (1987) Clomipramine, tryptophan and lithium in combination for resistant endogenous depression. Br J Psychiatr151: 213-217
56.
Hirschfeld R M A, Klerman G.L. (1979) Personality attributes and affective disorders . Am J Psychiatr136: 67-70
57.
Hirschfeld R M A, Klerman G.L., Andreasen N.C., Clayton P.J., Keller M.B. (1986) Psychosocial predictors of chronicity in depressed patients. Br J Psychiatr148: 648-654
Johnson D A W (1974) A study of the use of antidepressant medication in general practice. Br J Psychiatr125; 186-192
60.
Johnstone E.C., Owens D G C, Crow T.J., Colter N., Lawton R.J., Kreel L. (1986) Hypothyroidism as a correlate of lateral ventricular enlargement in manic depressive and neurotic illness. Br J Psychiatr148: 317-321
61.
Johnstone E.C., Cunningham Owens D.G. , Frith C.D., McPherson K., Dowie C., Riley G., Gold A. (1980) Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychol Med10: 321-32
62.
Kafka M.S., Nurnberger J.I., Siever L., Targum S., Uhde T.W., Gershon E.S. (1986) Alpha-2 adrenergic receptor function in patients with unipolar and bipolar affective disorders. J Affect Disorders10: 163-169
63.
Kagan B.L., Sultzer D.L., Rosenlicht N., Gerner R.H. (1990) Oral S-Adenosyl methionine in depression: a randomized, double blind, placebo controlled trial. Am J Psychiatr147: 591-595
64.
Kahn R.J., McNair D.M., Lipman R.S., Covi L., Rickels K., Downing R., Fisher S., Frankenthaler L.M. (1986) Imipramine and chlordiazepoxide in depressive and anxiety disorders. Arch Gen Psychiatr43: 79-84
Karliner W., Werheim H.K. (1965) Maintenance convulsive treatment. Am J Psychiatr121: 1113-1115
67.
Kay D W K, Fahy T., Garside R.F. (1970) A seven month double blind trial of amitriptyline and diazepam in ECT treated depressed patients. Br J Psychiatr117: 667-671
68.
Keller M.B., Klerman G.L., Lavori P.W., Fawcett J.A., Coryell W., Endicott J. (1982) Treatment received by depressed patients. J Am Med Assoc248: 1848-1855
69.
Keller M.B., Klerman G.L., Lavori P.W., Coryell W., Endicott J., Taylor J (1984) Long term outcome of episodes of major depression: clinical and public health significance. J Am Med Assoc255: 788-792
70.
Keller M.B., Lavori P.W., Rice J., Coryell W., Hirschfeld R.M. (1986a) The persistent risk of chronicity in recurrent episodes of non-bipolar major depressive disorder: a prospective follow up . Am J Psychiatr143: 24-28
71.
Keller M.B., Lavori P.W., Klerman G.L., Andreasen N.C., Endicott J., Coryell W., Fawcett J., Rice J.P., Hirschfeld R M A (1986b) Low levels and lack of predictors of somatotherapy and psychotherapy received by depressed patients. Arch Gen Psychiatr43: 458-466
72.
Keller M.B., Lavori PW, Coryell W., Andreasen N.C., Endicott J., Clayton P.J., Klerman G.L., Hirschfeld R M A (1986c) Differential outcome of pure manic, mixed/cycling a pure depressive episode in patients with bipolar illness. J Am Med Assoc255: 3138-3142
73.
Kerr T.A., Schapira K., Roth M. ( 1969) The relationship between premature death and affective disorders. Br J Psychiatr115: 1277-1282
74.
Kiloh L.G., Andrews G., Neilson M. (1988) The long-term outcome of depressive illness. Br J Psychiatr153: 752-757
75.
Kind D. ( 1958) Die Psychiatre der Hypophyseninsuflizienz Speziell der Simmondchen Krankheit. Forsch Neurol-Psychiatr26: 501-563Quoted in Gelder M, Gath D, Mayou R (eds), Oxford textbook of psychiatry. Oxford University Press
76.
Kirkegaard C., Faber J. (1981) Altered serum levels of thyroxine, triiodothyronines and diiodothyronines in endogenous depression. Acta Endocrinol96: 199-207
77.
Klein D., Taylor E.B., Dickstein S., Harding K. (1988) The early-late onset distinction in DSM III dysthymia . J Affect Disorders14: 25-33
78.
Kocsis J.H., Frances A.J., Voss C., Mason B.J., Mann J.J., Sweeney J. (1988) Imipramine treatment for chronic depression. Arch Gen Psychiatr45: 253-257
79.
Kocsis J.H., Mason B.J., Frances A.J., Sweeney J., Mann J.J., Marin D. (1989) Prediction of response of chronic depression to imipramine. J Affect Disorders17: 255-260
80.
Kraepelin E. (1904) Lectures on clinical psychiatry, 2nd edition. Translated by T Johnstone, Bailliere, Tindall and Cox, London, 1912
81.
Kraepelin E. (1920) Patterns of mental disorder. Reprinted in Hirsch S, Shepherd M (eds), Themes and variations in European psychiatry. Wright, Bristol, 1974
82.
Kupfer D.J., Carpenter L.L., Frank E. (1989) Possible role of antidepressants in precipitating mania and hypomania in recurrent depression. Am J Psychiatr145: 804-808
83.
Kupfer D.J., Frank E., Perel J.M. (1989) The advantage of early treatment intervention in recurrent depression. Arch Gen Psychiatr46: 771-775
Levitt A.J., Joffe R.T. (1989) Folate B12 and life course of depressive illness . Biol Psychiatr25: 867-872
86.
Liebowitz M.R., Quitkin F.M., Stewart J.W., McGrath P.J., Harrison W.M., Markowitz J.S., Rabkin J.G., Tricamo E., Goetz D.M., Klein D.F. (1988) Antidepressant specificity in atypical depression . Arch Gen Psychiatr45: 129-137
87.
Lishman W.A. (1987) Organic psychiatry: the psychological consequences of cerebral disorder. Second edn. Blackwell
88.
Loosen P.T., Prange A.J. (1982) Serum thyrotropin response to thyrotropin-releasing hormone in psychiatric patients: a review. Am J Psychiatr139: 405-416
89.
Lundquist G. (1945) Prognosis and course in manic-depressive psychosis: a follow up study of 519 first admissions. Acta Psychiatr Neurol Scand (Suppl) 35: 1-93
90.
Lusznat R.M., Murphy D.P., Nunn C M H (1988) Carbamazepine vs. lithium in treatment and prophylaxis of mania. Br J Psychiatr153: 198-204
Lydiard R.B., Ballenger J.C. (1987) Antidepressants in panic disorder and agoraphobia . J Affect Disorders13: 153-168
93.
McCreadie R.G., Wilson A D A, Burton L.L. (1983) The Scottish survey of new chronic inpatients. Br J Psychiatr143: 564-571
94.
McEwan G.W., Remick R.A. (1988) Treatment resistant depression: a clinical perspective . Can J Psychiatr33: 788-792
95.
MacFarland H.R. (1963) Addison's disease and related psychoses. Comp Psychiatr4: 90-95
96.
Maj M. ( 1988) Lithium prophylaxis of schizoaffective disorders : a prospective study. J Affect Disorders14 : 129-135
97.
Malizia A.L., Dawling S., Bridges P.K. (1990) Response to thioridazine in treatment resistant depression. J Psychopharmacol4: 257
98.
Mann S.A., Cree W. ( 1976) New long stay patients: a national survey of 15 mental hospitals in England and Wales 1972-3. Psychol Med6: 603-616
99.
Markowitz J., Brown R., Sweeny J., Mann J.J. (1987) Reduced length and cost of hospital stay for major depression in patients treated with ECT. Am J Psychiatr144: 1025-1029
100.
Margo A. (1981) Acromegaly and depression. Br J Psychiatr139: 467-468
101.
Munro A. (1966) Some familial and social factors in depressive illness. Br J Psychiatr112: 429-441
102.
Murphy G.E. (1974) Variability of the clinical course of primary affective disorder. Arch Gen Psychiatr30: 757-761
103.
Nelson J.C., Bowers M.B. (1978) Delusional unipolar depression: description and drug response. Arch Gen Psychiatr35: 1321-1328
104.
Nelson J.C., Charney D.S. (1981) The symptoms of major depressive illness. Am J Psychiatr138: 1-13
105.
Nelson J.C., Mazure C.M. (1986) Lithium augmentation in psychotic depression refractory to combined drug treatment. Am J Psychiatr143: 363-366
106.
Pare C M B (1963) Potentiation of monoamine oxidase inhibitors by tryptophan. Lancet2: 527-528
107.
Pare C M B (1965) Combining the antidepressant drugs. Br Med Ji : 384
108.
Paykel E.S. (1972) Depressive typologies and response to amitriptyline . Br J Psychiatr120: 147-156
109.
Paykel E.S. (1989) Treatment of depression: the relevance of research for clinical practice. (Maudsley lecture 1988). Br J Psychiatr155: 754-763
110.
Paykel E.S., Rowan P.R., Parker R.R., Ghat A.N. (1982) Response to phenelzine and amitriptyline in subtypes of outpatient depression. Arch Gen Psychiatr39: 1041-1049
111.
Petersen P. (1968) Psychiatric disorder in primary hyperthyroidism . J Clin Endocrinol Metab28: 1491-1495
112.
Pope H.G., Lipinski J.F. (1978) Diagnosis in schizophrenia and manic depressive illness: a reassessment of the specificity of 'schizophrenia' symptoms in the light of current research. Arch Gen Psychiatr35: 811-828
113.
Pope HG, McElroy SL, Nixon RA (1988) Possible synergism between fluoxetine and lithium in refractory depression. Am J Psychiatr145: 1292-1294
114.
Post F. ( 1976) Depression: behavioural, biochemical, diagnostic and treatment concepts. In Gallant D M, Simpson G M (eds). Spectrum Publications , NY
115.
Post R.M., Uhde T.W., Ballinger J.C. (1983) Prophylactic efficacy of carbamazepine in manic depressive illness. Am J Psychiatr140: 1602-1603
116.
Post R.M., Uhde T.W., Roy-Byrne P.P., Joffe R.T. (1986) Antidepressant effects of carbamazepine. Am J Psychiatr143: 29-34
117.
Prien R.F., Caffey E.M., Klett C.F. (1973) Prophylactic efficacy of lithium carbonate in manic-depressive illness. Arch Gen Psychiatr28: 337-341
118.
Price L.H., Conwell Y., Nelson J.C. (1983) Lithium augmentation of combined neuroleptic-tricyclic treatment in delusional depression. Am J Psychiatr140: 318-322
119.
Purzynski S., Klosiewicz L. (1984) Valproic acid in the treatment of affective and schizoaffective disorders. J Affect Disorders6: 115-121
120.
Quitkin F.M., McGrath P.J., Stewart J.W., Harrison W., Wager S.G., Nunes E., Rabkin J.G., Tricamo E., Markowitz J., Klein D.F. (1989) Phenelzine and imipramine in mood reactive depressives: further delineation of the syndrome of atypical depression. Arch Gen Psychiatr46: 787-793
121.
Raskin A., Crook T.A. (1976) The endogenous-neurotic distinction as a predictor of response to antidepressant drugs. Psychol Med6: 59-70
122.
Rihmer Z. (1990) Dysthymia: a clinician's perspective. In Burton S W, Akiskal H S (eds), Dysthymic disorder. Gaskell/ Royal College of Psychiatrists, pp. 112-125
123.
Robins A.H. (1976) Depression in patients with Parkinsonism. Br J Psychiatr128: 141-145
124.
Robins E., Guze S.B. (1972) Classification of affective disorders: the primary-secondary, the endogenous and the neurotic-psychotic concepts. In Williams T A, Katz M M, Shield J (eds), Recent advances in psychobiology of depressive illness. Department of Health Education and Welfare, Washington, DC
125.
Robinson R.G., Price T.R. (1982) Post stroke depressive disorders: a follow up study of 103 patients. Stroke13: 635-641
126.
Rodin G., Voshart K. (1986) Depression in the medically ill: an overview. Am J Psychiatr143: 696-705
127.
Rosenbaum J.F., Fava M., Falk W.E., Pollack M.H., Cohen L.S., Cohen B.M., Zubenko G.S. (1990) The antidepressant potential of oral S-adenosyl-methionine . Acta Psychiatr Scand81: 432-436
128.
Rounsaville B.J., Sholomaskas D., Prusoff B. (1980) Chronic mood disorders in depressed outpatients: diagnosis and response to pharmacotherapy. J Affect Disorders2: 73-88
129.
Rowan P.R., Paykel E.S., Parker R.R. (1982) Phenelzine and amitriptyline: effects on symptoms of neurotic depression. Br J Psychiatr140: 475-483
130.
Schneider K. (1959) Clinical psychopathology transl. M. HamiltonNew York, Grune & Stratton
131.
Scott J. (1988) Chronic depression. Br J Psychiatr153: 287-297
132.
Scott J., Barker W.A., Eccleston D. (1988) The Newcastle chronic depression study: patient characteristics and factors associated with chronicity. Br J Psychiatr152: 28-33
133.
Shaw D.M. (1977) The practical management of affective disorder . Br J Psychiatr130: 432-451
134.
Shaw D.M. (1983) Resistant depression in affective disorders-latest developments. Proceedings of the Boots company symposium, Boots, Nottingham
135.
Slater E., Roth M. ( 1969) In Mayer-Gross, Slater E, Roth M (eds), Clinical psychiatry. 3rd Edn, Baillière, Tindall and Cassel
136.
Spiker D.G., Weiss J.C., Dealy R.S., Griffin S.J., Hanin I., Neil J., Perel J.M., Rossi A.J., Soloff P.H. (1985) The pharmacological treatment of delusional depression . Am J Psychiatr142: 430-436
137.
Spitzer R., Endicott J., Robins E. (1975) Research Diagnostic Criteria (RDC) for a selected group of functional disorders. 2nd edn. New York Research Division, New York Psychiatric Institute
138.
Squire L. (1986) Memory functions as affected by electroconvulsive therapy. Ann NY Acad Sci462: 307-314
139.
Stewart JW, Quitkin F.M., McGrath P.J., Rabkin J.G., Markowitz J.S., Tricam D.E., Klein D.F. (1988) Social functioning in chronic depression: effects of 6 weeks of antidepressant treatment. Psychiatr Res25: 213-222
140.
Stewart J.W., McGarth P.J., Quitkin F.M., Harrison W., Markowitz J., Wager S., Leibowitz M.R. (1989) Relevance of DSM III depressive subtypes and chronicity of antidepressant efficacy in atypical depression. Arch Gen Psychiatr46: 1080-1087
141.
Taschev T. (1974) The course and prognosis of depression on the basis of 652 patients deceased. In Angst, J (ed.), Classification and prediction of outcome of depression. Springer Verlag, pp. 157-172
142.
Thomas F.B., Mazzaferi E.L., Skillman T.G. (1970) Apathetic thyrotoxicosis: a distinctive clinical and laboratory entity. Ann Intern Med72: 679-685
143.
Uhlenhuth E.H. (1982) Depressives, doctors and antidepressants. J Am Med Assoc248: 1879-1880
144.
Van Praag H.M. (1981) Management of depression with serotonin precursors . Biol Psychiatr16: 291-309
145.
Von Zerssen D. (1982) Personality and affective disorder. In Paykel E S (ed.), Handbook of affective disordersChurchill Livingstone, Edinburgh , pp. 212-228
146.
Walinder J. (1975) Potentiation of antidepressant action of clomipramine by tryptophan. Lanceti : 984
147.
Ward N.G., Bloom V.L., Friedel R.D. (1979) The effectiveness of tricyclic antidepressants in chronic depression. J Clin Psychiatr40: 49-52
148.
Wehr T.A., Goodwin F.K. (1979) Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatr36: 555-559
149.
Wehr T.A., Goodwin F.K. (1987) Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatr144: 1403-1411
150.
Weissman M.M., Akiskal H.S. (1984) The role of psychotherapy in chronic depression: a proposal. Comp Psychiatr25: 23-31
151.
Weissman M.M., Klerman G.L. (1977) The chronic depressive in the community: unrecognized and poorly treated. Comp Psychiatr18: 523-532
152.
Weissman M.M., Prusoff B.A., Di Mascio A., Neu C., Goklaney M., Klerman G.L. (1979a) The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatr136: 55
153.
Weissman M.M., Prusoff B.A., Klerman G.L. (1979b) Personality and the prediction of long term outcome of depression. Am J Psychiatr135: 797-800
154.
WHO Mental Health Collaborating Centres (1989 ) Pharmacotherapy of depressive disorders: a consensus statement . J Affect Disorders17: 197-198
155.
Wolfe J., Granholm E., Butters N., Saunders E., Janowsky D. (1987) Verbal memory deficits associated with major affective disorders: a comparison of unipolar and bipolar patients. J Affect Disorders13: 83-92
156.
Young J P R, Lader M.M., Hughes W.C. (1979) Controlled trial of monoamine oxidase inhibitors, and continued treatment in depressed outpatients. Br Med J2: 1315-1317
157.
Zohar J., Insel T.R. (1987) Drug treatment of obsessive compulsive disorder . J Affect Disorders13: 193-202
